BIMI International Medical Inc.
BIMIOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1156
P/E Ratio—
52W High$0.01
52W Low$0.0001
BIMI International Medical Inc. (BIMI) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BIMI · earnings · updated Jun 8, 2026
Latest Earnings
Q4 FY2023Report Date: Dec 19, 2023EPS Actual
-$0.49
Revenue
$0.00B
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Dec 19, 2023
After Market Close
BIMI reports quarterly as a OTC-listed Medical - Pharmaceuticals company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.06B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.06B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2024 | Sep 6, 2024 | — | — | — | — | — | — |
| ◌ Q3 FY2024 | Aug 22, 2024 | — | — | — | — | — | — |
| ◌ Q2 FY2024 | May 16, 2024 | — | — | — | — | — | — |
| ◌ Q4 FY2023 | Dec 29, 2023 | — | — | — | — | — | — |
| — Q4 FY2023 | Dec 19, 2023 | — | -$0.49 | — | $0.00B | — | — |
| — Q4 FY2023 | Nov 22, 2023 | — | $0.26 | — | $0.01B | — | — |
| — Q2 FY2023 | May 19, 2023 | — | -$0.24 | — | $0.00B | — | — |
| — Q2 FY2023 | May 4, 2023 | — | -$4.43 | — | $-0.01B | — | — |
Q3 FY2024
Sep 6, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 22, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
May 16, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Dec 29, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Dec 19, 2023
EPS Actual
-$0.49
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2023
Nov 22, 2023
EPS Actual
$0.26
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2023
May 19, 2023
EPS Actual
-$0.24
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2023
May 4, 2023
EPS Actual
-$4.43
EPS Est.
—
EPS Surpr.
—
Revenue
$-0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 1 |
| Q4 FY2023 | $2.09 | $2.09 | $2.09 | 1 |
| Q3 FY2023 | $1.39 | $1.39 | $1.39 | 7 |
| Q3 FY2011 | $0.38 | $0.48 | $0.58 | 16 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 8 |
| Q3 FY2011 | $0.0B | $0.0B | $0.0B | 16 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2023 | Dec 19, 2023 | — | $0.26 | $0.24 | -7.75% |
| — Q4 FY2023 | Nov 22, 2023 | — | $0.14 | $0.13 | -7.66% |
| — Q2 FY2023 | May 19, 2023 | — | $0.08 | $0.09 | +3.57% |
| — Q2 FY2023 | May 4, 2023 | — | $0.10 | $0.09 | -4.12% |
| — Q4 FY2022 | Nov 21, 2022 | — | $0.24 | $0.23 | -4.17% |
| — Q3 FY2022 | Aug 22, 2022 | — | $0.45 | $0.56 | +24.44% |
| — Q2 FY2022 | May 20, 2022 | — | $0.60 | $0.59 | -1.67% |
| — Q2 FY2022 | Apr 18, 2022 | — | No price data | $1.09 | — |
Q4 FY2023-7.75%
Report Date
Dec 19, 2023
EPS Beat/Miss
—
Price Before
$0.26
Price After
$0.24
Q4 FY2023-7.66%
Report Date
Nov 22, 2023
EPS Beat/Miss
—
Price Before
$0.14
Price After
$0.13
Q2 FY2023+3.57%
Report Date
May 19, 2023
EPS Beat/Miss
—
Price Before
$0.08
Price After
$0.09
Q2 FY2023-4.12%
Report Date
May 4, 2023
EPS Beat/Miss
—
Price Before
$0.10
Price After
$0.09
Q4 FY2022-4.17%
Report Date
Nov 21, 2022
EPS Beat/Miss
—
Price Before
$0.24
Price After
$0.23
Q3 FY2022+24.44%
Report Date
Aug 22, 2022
EPS Beat/Miss
—
Price Before
$0.45
Price After
$0.56
Q2 FY2022-1.67%
Report Date
May 20, 2022
EPS Beat/Miss
—
Price Before
$0.60
Price After
$0.59
Q2 FY2022—
Report Date
Apr 18, 2022
EPS Beat/Miss
—
Price Before
—
Price After
$1.09
Beat Rate0 / 8 quarters
Largest Move+24.44% (Q3 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BIMI ends December
BIMI International Medical Inc. (BIMI) most recently reported earnings on December 19, 2023 for Q4 FY2023, posting EPS of $-0.49 (in line with the analyst consensus of —). The next BIMI earnings date is expected around September 1, 2026.
Each quarter, investors track BIMI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BIMI revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BIMI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BIMI earnings · 4 questionsBIMI International Medical Inc.'s next earnings report is expected around September 1, 2026. BIMI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BIMI historically reports after market close (AMC).
BIMI earnings datewhen is BIMI earningsBIMI next earnings datewhen does BIMI report earningsBIMI earnings calendar
▸ Source: FMP · BIMI International Medical Inc. SEC filings · US GAAP · BIMI International Medical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026